SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
28-Mar-22 9:06 PM View: | Marker Therapeutics, Inc. (MRKR) | 24-Mar-22 | Grant | 199,094 | -- | -- | 60% 332.57K to 531.66K | |
28-Mar-22 9:06 PM View: | Marker Therapeutics, Inc. (MRKR) | 24-Mar-22 | Payment of Exercise | 48,376 | $0.48 | $23,452.70 | (9%) 531.66K to 483.29K | |
18-Mar-21 4:36 PM View: | Marker Therapeutics, Inc. (MRKR) | 16-Mar-21 | Market Purchase | 142,857 | $1.75 | $250,000.00 | 75% 189.71K to 332.57K | (100%) |
15-Aug-19 4:33 PM View: | Marker Therapeutics, Inc. (MRKR) | 14-Aug-19 | Market Purchase | 10,000 | $4.62 | $46,200.00 | 6% 179.71K to 189.71K | |
25-Sep-17 3:11 PM View: | Marker Therapeutics, Inc. (MRKR) | 22-Sep-17 | Grant | 250,000 | $3.18 | $795,000.00 | 100% 0 to 250.0K | (100%) |
25-Sep-17 3:11 PM View: | Marker Therapeutics, Inc. (MRKR) | 22-Sep-17 | Payment of Exercise | 70,289 | $3.18 | $223,519.00 | (28%) 250.0K to 179.71K | (100%) |